Radiopharmaceuticals lie at the forefront of nuclear medicine, bridging the gap between molecular targeting and therapeutic intervention. These compounds, infused with radioactive isotopes, are designed to treat and diagnose diseases, principally cancer. As the field evolves, the need to precisely understand how these agents behave within the body becomes paramount. This...